Patient Blood Management in Patients Scheduled for Cardiac Surgery
Patient Blood Management in Cardiac Surgical Patients: the ICARUS-2 Study
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
464 participants
Feb 24, 2025
OBSERVATIONAL
Conditions
Summary
The ICARUS 2 study has the general objective of collecting data in patients undergoing cardiac surgery; in our centre, in order to optimize and improve hemoglobin values, a team of haematologists, assisted by cardio anesthetists and cardiac surgeons, will evaluate the blood tests of patients scheduled for elective cardiac surgery in order to correct any states of hypoferritinemia (low iron in the blood) to promote recovery from blood losses related to cardiac surgery. This objective is strongly encouraged by the good use of blood programs currently in force at our foundation. In particular, the research presented here intends to demonstrate a reduction in the number of intra- and post-operative transfusions.
Eligibility
Inclusion Criteria1
- \- all adult patients scheduled for elective cardiac surgery
Exclusion Criteria3
- pregnancy
- dyalisis
- patient's refusal
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients who present a state of hypoferritinemia or a state of reduced transferrin saturation will undergo administration of i.v iron at least 2 weeks before scheduled cardiac surgery, plus acid folic and B vitamin co-administration.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06637137